We retrospectively reviewed the characteristics and clinical outcomes of all living renal donors who underwent surgery from January 1990 to December 2015 at a teaching hospital in Hong Kong. Information was obtained from hospital records and territory-wide electronic patient records.
Introduction
Chronic kidney disease (CKD) is the progressive loss of kidney function over a period of time. Endstage renal disease (ESRD) is the final stage of CKD. Patients with ESRD require renal replacement therapy that includes haemodialysis, peritoneal dialysis, and renal transplantation.
Currently, there are approximately 7000 patients on various forms of renal replacement New knowledge added by this study • The overall perioperative outcomes are good, with very few serious complications, among living renal donors.
The introduction of a laparoscopic approach has decreased perioperative blood loss and also shortened hospital stay.
• Long-term kidney function was satisfactory and no patients developed end-stage renal disease (ESRD).
• The incidences of new-onset medical disease and pregnancy-related complications were also low.
Implications for clinical practice or policy
• Medical practitioners should encourage relatives of patients with ESRD to consider the possibility of kidney donation.
therapy being cared for in the public sector in Hong Kong. As of 31 December 2016, 2047 patients were on the renal transplant waiting list. Nonetheless, between 2007 and 2016, only 58 to 87 cadaveric renal transplants were performed in Hong Kong each year. 1 With the long waiting list and low number of cadaveric kidneys available, living donor renal transplant is the only possible alternative. It offers advantages over other renal replacement
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Of the donors, 14 (18.2%) developed hypertension, two (2.6%) had diabetes mellitus, and three (4.0%) had experienced proteinuria.
Conclusion:
The overall perioperative outcomes are good, with very few serious complications. The introduction of a laparoscopic approach has decreased perioperative blood loss and also shortened hospital stay. Long-term kidney function is satisfactory and no patients developed end-stage renal disease. The incidences of new-onset medical diseases and pregnancy-related complications were also low. One of the major fears of an individual who is considering living organ donation concerns possible clinical outcomes. Although studies show that living donors have a similar to or better life expectancy than the general population, they are nevertheless at increased risk of developing ESRD, hypertension, gestational hypertension, and pre-eclampsia. [2] [3] [4] In Hong Kong, few reports on the perioperative, short-term, and long-term clinical outcomes are available, especially those related to the minimally invasive surgical approach now employed for donor nephrectomy. This study reports our observation of characteristics of donors, and the short-and long-term clinical outcomes following living donor nephrectomy in Hong Kong.
Methods

Study design
We retrospectively reviewed the characteristics and 
Study measures
Baseline demographics including sex, age at donation, ethnicity, relationship with recipient, diabetes mellitus status, hypertension status, body mass index, and serum creatinine level were obtained. Glomerular filtration rate (GFR) was derived from the serum creatinine level using a modified equation from the Modification of Diet in Renal Disease (MDRD) study. 5 Operation details, including surgical approach, laterality of donated kidney, operating time, warm ischaemia time, blood loss, and need for transfusion were retrieved.
Short-term complications within 30 days of surgery were classified according to the ClavienDindo classification of surgical complications. 6 Longterm outcomes were also assessed, with particular reference to development of hypertension, diabetes mellitus, renal stones, proteinuria, and renal failure. Serial changes in GFR were also assessed.
For female donors, pregnancy-related variables were recorded and included any pregnancy after surgery, records of pregnancyrelated hydronephrosis, pregnancy-related urinary tract infection, pre-eclampsia, gestational diabetes mellitus, gestational hypertension, and any fetal loss. 
Statistical analyses
Results
Donor characteristics
Between 1 January 1990 and 31 December 2015, a total of 83 donors underwent unilateral nephrectomy at the Prince of Wales Hospital. In one donor, records could not be traced, with only information about the sex, age at nephrectomy, and type of surgical technique.
Of the 83 donors, 56 (67.5%) were female. The mean age at nephrectomy was 37.3 ± 10.0 years. The majority were Chinese (97.6%) and a first-degree relative of the recipient (79.3%). None had hypertension or diabetes mellitus. The mean preoperative GFR was 96.0 ± 17.5 mL/min/1.73 m 2 . Nine (11.0%) donors had thalassaemia trait, four (4.9%) had hepatitis B, and two (2.4%) had asthma (Table 1) .
Operation details and short-term outcomes
Around half (n=44, 53.0%) of the donors underwent open living donor nephrectomy, as this was the only technique used at our centre until 2002. After 2002, a hand-port assisted laparoscopic approach (n=4, 4.8%) and later a laparoscopic approach (n=35, 42.2%) were adopted. In most instances, the left kidney was donated (n=77, 93.9%) [ Table 2 ].
Comparing laparoscopic or hand-port assisted laparoscopic living donor nephrectomy (LDN) with open donor nephrectomy (ODN), LDN was associated significantly with longer warm ischaemia time (309.0 ± 113.0 s vs 62.0 ± 17.9 s; P<0.01), less blood loss (55.3 ± 33.7 mL vs 532.2 ± 270.0 mL; P<0.01), and shorter hospital stay (5.7 ± 2.0 days vs 8.1 ± 1.9 days; P<0.01). In addition, LDN was associated significantly with more short-term complications (53.8% vs 20.9%; P<0.01). The most commonly experienced complication was epigastric pain/nausea and vomiting (n=18, 56.3%), followed by fever requiring medication (n=4, 12.5%). Most complications were grade 1 on the Clavien-Dindo classification scale (n=16, 50.0%), only three (9.4%) were grade 3a and all were related to ODN. The grade 3a complications were wound dehiscence that required a second operation for re-suturing, persistent pancreatic fluid discharge that required insertion of a pancreatic stent, and pneumothorax with chest drain inserted.
Long-term outcomes
The mean follow-up time was 12.0 ± 8.3 years. The mean GFR was 96.0 ± 17.5 mL/min/1.73 m 2 at baseline and it dropped significantly to 66.8 ± 13.5 mL/min/1.73 m 2 at 1-year follow-up (P<0.01). The GFR then gradually improved until 8 years after surgery and became stable (Fig) . Of 73 living donors with at least one follow-up (mean follow-up time, 12.0 ± 8.2 years) and baseline serum creatinine level available, the latest GFR was 75.6% ± 15.1% of baseline GFR with the mean latest GFR being 71.3 ± 14.2 mL/min/1.73 m 2 . The mean GFR was 70.4% ± 12.3% of baseline level 1 year after surgery. Comparison of latest GFR with that 1 year after surgery revealed that it was stable (± 10% change) in 23 (39.0%) of 59 patients and higher (>10% increment) in 29 (49.2%) patients. None of the donors had died or developed ESRD. Fourteen (18.2%) donors developed hypertension, two (2.6%) had diabetes mellitus, and three (4.0%) had experienced proteinuria (Table 3) .
Pregnancy-related complications
Of 56 female donors, 11 (19.6%) became pregnant after kidney donation: 17 pregnancies were reported. None of the pregnant donors experienced gestational hydronephrosis or gestational hypertension. Three donors each had gestational diabetes mellitus, pre- Other health condition, n=82
With thalassaemia trait 9 (11.0) Hepatitis B carrier 4 (4.9) Asthma
(2.4)
Abbreviations: BMI = body mass index; Cr = creatinine; GFR = glomerular filtration rate; SD = standard deviation eclampsia, and post-delivery urinary tract infection. Two donors had experienced fetal loss, one in the first trimester and another one at an unknown gestational age (Table 4) .
Discussion
Postoperative morbidity and mortality are the prime concerns when making a decision about kidney donation. Our results confirm that living donor nephrectomy is a relatively safe procedure, with a low incidence of major complications and mortality. In addition, the incidence of developing any other major disease was not particularly high in our series. This form of renal replacement therapy should be further promoted in Hong Kong to benefit more people with ESRD.
Results from previous studies have shown that living renal donors have a similar to or better life expectancy than the general population.
7-10 Mjøen et al, 11 however, reported that compared with healthy matched individuals, living renal donors had an increased risk of death. In Hong Kong, Chu et al 12 reported one death related to multiple myeloma among 95 living renal donors with active follow-up and a mean follow-up period of 13.4 years. There were no deaths recorded in our study with a mean follow-up of 12 years.
Long-term renal function is another major concern of renal donors. Our results revealed that 1 year after living donor nephrectomy, the mean GFR of the kidney donors dropped significantly from 96.0 ± 17.5 mL/min/1.73 m 2 at baseline to 66.8 ± 13.5 mL/min/1.73 m 2 . Nonetheless, it then gradually improved. This is probably partly related to the adaptation of the remaining kidney with hyperfiltration. From our series, the mean GFR was 70.4% ± 12.3% of baseline level 1 year after surgery but improved to 75.6% ± 15.1% of baseline level at the last follow-up. In the majority (88.2%) of donors, the last available GFR was static or higher than that 1 year after donation. This is comparable with the report of Rook et al 13 in which GFR usually reached 64% ± 7% of the pre-donation level 1 year after donation.
Despite these changes in GFR, ESRD in renal donors is very rare, with an incidence of less than 0.5% in 15 years after donation. 11, 14, 15 Ibrahim et al 8 reported that survival and risk of ESRD in kidney donors appeared to be similar to those in the general population. Our study and that of Chu et al 12 observed no ESRD in local kidney donors. The effect of kidney donation on the development of hypertension is controversial. Although reports suggest that the incidence of hypertension among kidney donors increases, [16] [17] [18] [19] others have not confirmed this observation. [20] [21] [22] [23] [24] In Hong Kong, the prevalence of hypertension in the general population was 12.6% in 2014, 25 which is lower than our reported figure of 18.2%. With the progression of time after surgery, however, the prevalence of hypertension among living donors is expected to increase as age is a known influence in hypertension. Without a comparable control group, we cannot conclude if there is any actual discrepancy in the prevalence of hypertension among living donors compared with the general population.
Young female potential donors may have concerns about the impact of kidney donation on any future pregnancy. Garg et al 4 reported that gestational hypertension or pre-eclampsia was more common among living donors than non-donors. Although our study showed an alarmingly high percentage (11%) of pre-eclampsia and absence of gestational hypertension, the small sample size (11 donors reported one or more pregnancies) undermines the ability to infer the actual percentage.
Perioperative complications may also deter potential living donors. Based on the US data, Lentine et al 26 reported that 16.8% of donors experience a perioperative complication; most commonly gastrointestinal (4.4%). Our study showed a higher complication rate of 36.6%, with epigastric pain or nausea and vomiting being the major complication (56.3%). We further examined the techniques used and established that the complication rates of 20.9% or 53.8% respectively in donors who underwent ODN or LDN were significantly different (P<0.01). Despite the above mean complication rates, all complications of LDN were mild and of grade 1 or 2 according to the Clavien-Dindo classification, while three patients who underwent ODN had grade 3a complications. This is contrary to the majority of previous findings that suggest a lower perioperative complication rate for LDN and increased risk of more serious complications than during an ODN, 27 although other indicators such as longer warm ischaemia time, less blood loss, and shorter hospital stays were still in line with previous findings. Further analysis of the differences between our local data and those of previous studies is warranted.
This study has several limitations. First, this was a retrospective study and the total number of living donors was restricted. Second, data quality could not be controlled and some data were incomplete, in particular for the obstetric records at other hospitals. Some data were also lost either because records were too old and pre-dated the electronic system or donors were no longer followed up at our centre. The oldest record included in the study was from 1990. At that time, record keeping was not always accurate, resulting in some baseline records from the early 1990s being missing. For example, the baseline GFR level of seven (8.4%) patients was not found, and might have affected the overall data quality as well as the analysis and conclusion. Third, although the urologist endeavoured to ensure accurate data entry, initial interpretation of the raw records was by medical students so certain inaccuracies might have occurred. Lastly, it is known that GFR might be underestimated when derived from the MDRD equation.
Conclusion
Living donor kidney transplantation is an important approach to improve the quality of life of patients with ESRD. Good short-and long-term outcome for kidney donors is important for promoting kidney donation. Our results suggest that the overall perioperative outcomes are good, with only very few serious (grade III) complications after surgery, occurring following an open approach. Long-term kidney function of donors was satisfactory and no patients developed ESRD. Although we had no control arm in our study, the overall incidences of new-onset medical diseases and pregnancy-related complications were low. The introduction of a laparoscopic approach for kidney harvesting has helped to decrease blood loss during surgery and also shorten hospital stay. Based on this encouraging result, relatives of patients with ESRD should be encouraged to consider the possibility of kidney donation.
